These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26314953)

  • 81. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community.
    Manjunath G; Tighiouart H; Ibrahim H; MacLeod B; Salem DN; Griffith JL; Coresh J; Levey AS; Sarnak MJ
    J Am Coll Cardiol; 2003 Jan; 41(1):47-55. PubMed ID: 12570944
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Salivary Alpha-Amylase Activity in Relation to Cardiometabolic Status in Japanese Adults without History of Cardiovascular Disease.
    Ikeda A; Steptoe A; Brunner EJ; Maruyama K; Tomooka K; Kato T; Miyoshi N; Nishioka S; Saito I; Tanigawa T
    J Atheroscler Thromb; 2021 Aug; 28(8):852-864. PubMed ID: 33041312
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Prediction of incident atherosclerotic cardiovascular disease with polygenic risk of metabolic disease: Analysis of 3 prospective cohort studies in Korea.
    Song H; Koh Y; Rhee TM; Choi SY; Kang S; Lee SP
    Atherosclerosis; 2022 May; 348():16-24. PubMed ID: 35390551
    [TBL] [Abstract][Full Text] [Related]  

  • 84. The association between breast arterial calcification and atherosclerotic cardiovascular disease in an Australian population-based breast cancer case-control study.
    Lee SC; Pirikahu S; Fritschi L; Boyle T; Schultz C; Wylie E; Stone J
    Radiol Med; 2023 Apr; 128(4):426-433. PubMed ID: 36877422
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Fasting blood glucose and risk of cardiovascular disease.
    Balkau B; Jarrett RJ; Pyörälä K; Eschwège E
    Diabetes Care; 1999 Aug; 22(8):1385-7. PubMed ID: 10480797
    [No Abstract]   [Full Text] [Related]  

  • 86. Circulating sphingolipids, fasting glucose, and impaired fasting glucose: The Strong Heart Family Study.
    Jensen PN; Fretts AM; Yu C; Hoofnagle AN; Umans JG; Howard BV; Sitlani CM; Siscovick DS; King IB; Sotoodehnia N; McKnight B; Lemaitre RN
    EBioMedicine; 2019 Mar; 41():44-49. PubMed ID: 30594552
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Postload plasma glucose concentration and 27-year prostate cancer mortality (United States).
    Gapstur SM; Gann PH; Colangelo LA; Barron-Simpson R; Kopp P; Dyer A; Liu K
    Cancer Causes Control; 2001 Oct; 12(8):763-72. PubMed ID: 11562117
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Association between random glucose and all-cause mortality: findings from the mortality follow-up of the German National Health Interview and Examination Survey 1998.
    Baumert J; Heidemann C; Paprott R; Du Y; Scheidt-Nave C
    BMC Endocr Disord; 2018 Dec; 18(1):95. PubMed ID: 30545323
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Role of Late-Life Depression in the Association of Subclinical Cardiovascular Disease With All-Cause Mortality: Cardiovascular Health Study.
    Armstrong NM; Carlson MC; Xue QL; Schrack J; Carnethon MR; Chaves PHM; Gross AL
    J Aging Health; 2019 Apr; 31(4):652-666. PubMed ID: 29254423
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Associations of visit-to-visit fasting glucose with risk of mortality: A retrospective cohort study of 48,077 people with type 2 diabetes.
    Xu H; Zhang Y; Xu W; Chen L; Zhang M; Su H; Cheng Y; Zhao N; Xu D; Qin G
    Diabetes Metab; 2021 Feb; 47(1):101161. PubMed ID: 32470380
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Letter to the Editor: One-Hour Postload Hyperglycemia is a Stronger Predictor of Type 2 Diabetes than Impaired Fasting Glucose.
    Marathe CS; Rayner CK; Jones KL; Horowitz M
    J Clin Endocrinol Metab; 2016 Feb; 101(2):L33-4. PubMed ID: 26840117
    [No Abstract]   [Full Text] [Related]  

  • 92. Heritability of and mortality prediction with a longevity phenotype: the healthy aging index.
    Sanders JL; Minster RL; Barmada MM; Matteini AM; Boudreau RM; Christensen K; Mayeux R; Borecki IB; Zhang Q; Perls T; Newman AB
    J Gerontol A Biol Sci Med Sci; 2014 Apr; 69(4):479-85. PubMed ID: 23913930
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Ten-year atherosclerotic cardiovascular disease risk prediction for postmenopausal women: Impacts of isolated postchallenge hyperglycemia.
    Wu TH; Lin YC; Hwu CM
    Medicine (Baltimore); 2022 Sep; 101(36):e30352. PubMed ID: 36086734
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Visit-to-visit changes in fasting blood sugar and the risk for cardiovascular disease and mortality in the Korean population: a nationwide population-based cohort study.
    An HM; Yeo SH; Chung HJ; Cho HS; Bae SJ; Kim JY; Kang DR; Lee MY; Lee JY
    Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):263-272. PubMed ID: 33506915
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The sweet spot: continued search for the glycemic threshold for macrovascular disease-a retrospective single center experience.
    Boguszewski A; Teklinski A; Rosman H; Desai D; Ali S; Szpunar S; Moore R; Maciejko J
    ISRN Cardiol; 2012; 2012():874706. PubMed ID: 23097721
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Correlates of atherosclerotic cardiovascular disease risk in older Colorado firefighters.
    Li K; Ochoa E; Lipsey T; Nelson T
    Occup Med (Lond); 2018 Feb; 68(1):51-55. PubMed ID: 29351620
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Management of Atherosclerotic Cardiovascular Disease Risk Factors in the Older Adult Patient With Diabetes.
    Korytkowski MT; Forman DE
    Diabetes Care; 2017 Apr; 40(4):476-484. PubMed ID: 28325797
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Metabolite Profiles of Healthy Aging Index Are Associated With Cardiovascular Disease in African Americans: The Health, Aging, and Body Composition Study.
    Yeri A; Murphy RA; Marron MM; Clish C; Harris TB; Lewis GD; Newman AB; Murthy VL; Shah RV
    J Gerontol A Biol Sci Med Sci; 2019 Jan; 74(1):68-72. PubMed ID: 29253112
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Non-fasting lipid profile for cardiovascular risk assessments using China ASCVD risk estimator and Europe SCORE risk charts in Chinese participants.
    Zhang SL; Du X; Xu J; Xiang QY; Liu L
    Cardiovasc Diagn Ther; 2021 Aug; 11(4):991-1001. PubMed ID: 34527522
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Glycemia and Atherosclerotic Cardiovascular Disease: Exploring the Gap Between Risk Marker and Risk Factor.
    Nahmias A; Stahel P; Xiao C; Lewis GF
    Front Cardiovasc Med; 2020; 7():100. PubMed ID: 32582769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.